Boothbay Fund Management, LLC Aptinyx Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.21 - $2.89 $30,690 - $40,133	-13,887 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.39 - $3.5 $33,189 - $48,604	13,887 New	13,887 $39,000
Q4 2020 Feb 12, 2021	SELL	$2.93 - $4.3 $200,113 - $293,681	-68,298 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.05 - $4.99 $195,703 - $320,183	-64,165 Reduced 48.44%	68,298 $231,000
Q2 2020 Aug 14, 2020	BUY	$1.99 - $4.4 $101,490 - $224,400	51,000 Added 62.61%	132,463 $552,000
Q1 2020 May 15, 2020	BUY	$1.81 - $5.03 $147,448 - $409,758	81,463 New	81,463 $176,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.